V
58
-14
ALLE
60
7
HSIC
59
2
CMS
57
3
NEE
70
2
UNM
62
3
ORCL
71
3
PLD
46
6
CNP
52
3
SEE
63
2
ORLY
62
5
CME
61
2
HOG
42
3
UA
48
-8
O
37
7
MCHP
60
-5
WU
38
6
CF
56
3
WYNN
46
-2
FIS
68
3
V
58
-14
ALLE
60
7
HSIC
59
2
CMS
57
3
NEE
70
2
UNM
62
3
ORCL
71
3
PLD
46
6
CNP
52
3
SEE
63
2
ORLY
62
5
CME
61
2
HOG
42
3
UA
48
-8
O
37
7
MCHP
60
-5
WU
38
6
CF
56
3
WYNN
46
-2
FIS
68
3
Financhill
Back

Monopar Therapeutics Stock Predictions

This Tech Company Grew 32,481%...

This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
50

MNPR
Monopar Therapeutics

Last Price:
$37.84
Seasonality Move:
-15.23%

7 Day Trial

ALL ACCESS PASS

$ 7

Monopar Therapeutics Stock Forecast

  • Over the next 52 weeks, Monopar Therapeutics has on average historically risen by 144.9% based on the past 5 years of stock performance.
  • Monopar Therapeutics has risen higher in 1 of those 5 years over the subsequent 52-week period, corresponding to a historical accuracy of 20%
  • Is Monopar Therapeutics Stock Undervalued?
    The current Monopar Therapeutics [MNPR] share price is $37.16. The Score for MNPR is 50, which is 0% below its historic median score of 50, and infers higher risk than normal.
  • MNPR is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.

Will Monopar Therapeutics Stock Go Up Next Year?

  • Over the next 52 weeks, Monopar Therapeutics has on average historically risen by 144.9% based on the past 5 years of stock performance.

Monopar Therapeutics Stock Rating

Sell
50
Monopar Therapeutics (MNPR) is a Sell

Is Monopar Therapeutics overpriced?

  • Monopar Therapeutics has risen higher in 1 of those 5 years over the subsequent 52-week period, corresponding to a historical accuracy of 20%

Monopar Therapeutics Stock Price History

Is MNPR stock going to rise?

  • The current trend is relatively stagnant and MNPR is experiencing slight selling pressure.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
monopartx.com

52-Week Data

52-Week High:
54.30
52-Week Low:
1.72

Prediction Charts

Market Cap:
227.2M
Price in USD:
37.16
Volume:
14.8K
Beta:
1.32

Technical Analysis

SMA50:
37.20
SMA100:
35.90
SMA200:
23.18
52-Wk Change:
1103.56%

Stock Predictions

  • Is Monopar Therapeutics stock public?
    Yes, Monopar Therapeutics is a publicly traded company.
  • What is the Monopar Therapeutics stock quote today?
    The Monopar Therapeutics stock price is 37.16 USD today.
  • How to buy Monopar Therapeutics stock online?
    You can buy Monopar Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Apr-29 40.37 41.96 42.00 39.62
Apr-30 41.11 41.82 42.90 40.12
May-1 40.59 43.15 43.78 40.59
May-2 41.96 44.96 44.99 41.87
May-5 43.77 43.36 46.60 43.30
May-6 40.25 38.78 43.59 38.78
May-7 40.70 39.10 40.70 37.81
May-8 40.45 42.37 44.40 40.42
May-9 41.89 39.42 43.85 39.01
May-12 39.68 35.10 40.20 34.45
May-13 35.10 33.82 37.87 33.34
May-14 32.97 37.11 38.87 32.97
May-15 36.21 39.55 40.10 33.70
May-16 40.33 37.16 40.33 35.65

Monopar Therapeutics Earnings

Monopar Therapeutics Earnings Report: Per Share Monopar Therapeutics Earnings Q1 Q2 Q3 and Q4 last year and next year.

Monopar Therapeutics Forecast Revenue Growth

Monopar Therapeutics Stock Analysis: Historical quarterly revenues per share for Monopar Therapeutics and historical quarterly revenue growth:

  • Analysts estimate an earnings decrease this quarter of $0.53 per share, an increase next quarter of $0.02 per share, a decrease this year of $0.77 per share, and an increase next year of $0.41 per share.

* Monopar Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.